Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;9(1):97-101.
doi: 10.1093/ckj/sfv126. Epub 2015 Nov 30.

Rapidly progressive glomerulonephritis due to coexistent anti-glomerular basement membrane disease and fibrillary glomerulonephritis

Affiliations

Rapidly progressive glomerulonephritis due to coexistent anti-glomerular basement membrane disease and fibrillary glomerulonephritis

Wisit Cheungpasitporn et al. Clin Kidney J. 2016 Feb.

Abstract

Anti-glomerular basement membrane (anti-GBM) disease is a major cause of rapidly progressive glomerulonephritis (RPGN). On the other hand, fibrillary glomerulonephritis (GN) typically presents as proteinuria, hematuria and renal insufficiency, but rarely as RPGN. Without electron microscopy, the diagnosis of fibrillary GN can be missed. We report a 68-year-old white woman who presented with RPGN with kidney biopsy demonstrating diffuse crescentic GN on light microscopy. By immunofluorescence, there was bright linear staining of the GBMs and smudgy mesangial staining for immunoglobulin G, C3, and kappa and lambda light chain. Electron microscopy revealed fibrillary deposits in the GBM and mesangium. A serum test for anti-GBM antibody was positive. To our knowledge, this is the first report of coexistence of fibrillary GN in a patient with anti-GBM disease. Electron microscopy is critical to identify the coexistence of other GN in patients presenting with crescentic GN.

Keywords: anti-GBM; anti-glomerular basement membrane disease; crescentic glomerulonephritis; fibrillary glomerulonephritis; rapidly progressive glomerulonephritis.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Representative kidney biopsy findings showing FGN with anti-GBM disease. (A) Glomerulus with cellular crescent and mild mesangial matrix expansion. Associated interstitial inflammation is noted (periodic acid–Schiff, 40×). (B) Immunofluorescence staining with IgG demonstrates linear GBM staining as well as segmental smudgy mesangial staining. (C) Electron microscopy shows randomly oriented nonbranching fibrils distributed within mesangium as well as within the peripheral capillary loops.

Similar articles

Cited by

References

    1. Couser WG. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 1988; 11: 449–464 - PubMed
    1. Iskandar SS, Falk RJ, Jennette JC. Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int 1992; 42: 1401–1407 - PubMed
    1. Fogo A, Qureshi N, Horn RG. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis 1993; 22: 367–377 - PubMed
    1. Alpers CE. Immunotactoid (microtubular) glomerulopathy: an entity distinct from fibrillary glomerulonephritis? Am J Kidney Dis 1992; 19: 185–191 - PubMed
    1. Sharma P, Kuperman M, Racusen L, et al. Fibrillary glomerulonephritis presenting as rapidly progressive glomerulonephritis. Am J Kidney Dis 2012; 60: 157–159 - PubMed